Cholinesterase inhibitors affect brain potentials in amnestic mild cognitive impairment

Brain Research

Volumn 1145, Issue 1, 2007, Pages 108-116

  Irimajiri, Rie ^a   Michalewski, Henry J ^a   Golob, Edward J ^b   Starr, Arnold ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TULANE UNIVERSITY   (United States)

Author keywords

Cholinesterase inhibitor; Mild cognitive impairment; Somatosensory cortex; Visual cortex

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; AMNESTIC MILD COGNITIVE IMPAIRMENT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFECT; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MEDIAN NERVE; MEMORY DISORDER; NERVE STIMULATION; NEUROMODULATION; PRIORITY JOURNAL; SENSORY CORTEX; TREATMENT OUTCOME;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; AGING; AMNESIA; BRAIN; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; ELECTRIC STIMULATION; EVOKED POTENTIALS; EVOKED POTENTIALS, SOMATOSENSORY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PHOTIC STIMULATION; REACTION TIME; TREATMENT OUTCOME;

EID: 33947696103     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.120     Document Type: Article

References (54)

1. Allison T. Scalp and cortical recordings of initial somatosensory cortex activity to median nerve stimulation in man. Ann. N.Y. Acad. Sci. 388 (1982) 671-678
2. Bajalan A.A., Wright C.E., and van der Vliet V.J. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 49 (1986) 175-182
3. Bell-McGinty S., Lopez O.L., Meltzer C.C., Scanlon J.M., Whyte E.M., Dekosky S.T., and Becker J.T. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch. Neurol. 62 (2005) 1393-1397
4. Celesia G.G., and Daly R.F. Effects of aging on visual evoked responses. Arch. Neurol. 34 (1977) 403-407
5. Davis K.L., Mohs R.C., Marin D., Purohit D.P., Perl D.P., Lantz M., Austin G., and Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. J. Am. Med. Assoc. 281 (1999) 1401-1406
6. Desmedt J.E., and Cheron G. Somatosensory evoked potentials to finger stimulation in healthy octogenarians and in young adults: wave forms, scalp topography and transit times of parietal and frontal components. Electroencephalogr. Clin. Neurophysiol. 50 (1980) 404-425
7. Desmedt J.E., and Cheron G. Non-cephalic reference recording of early somatosensory potentials to finger stimulation in adult or aging normal man: differentiation of widespread N18 and contralateral N20 from the prerolandic P22 and N30 components. Electroencephalogr. Clin. Neurophysiol. 52 (1981) 553-570
8. Dick M.B., Hsieh S., Bricker J., and Dick-Muehlke C. Facilitating acquisition and transfer of a continuous motor task in healthy older adults and patients with Alzheimer's disease. Neuropsychology 17 (2003) 202-212
9. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., Daniele A., Ghirlanda S., Gainotti G., and Tonali P. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75 (2004) 555-559
10. Di Lazzaro V., Oliviero A., Pilato F., Saturno E., Dileone M., Marra C., Ghirlanda S., Ranieri F., Gainotti G., and Tonali P. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1064-1069
11. Doody R.S., Dunn J.K., Clark C.M., Farlow M., Foster N.L., Liao T., Gonzales N., Lai E., and Massman P. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12 (2001) 295-300
12. Ducati A., Fava E., and Motti E. Neuronal generators of the visual evoked potentials: intracerebral recording in awake humans. Electroencephalogr. Clin. Neurophysiol. 71 (1988) 89-99
13. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
14. Geula C., and Mesulam M.M. Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 33 (1989) 469-481
15. Goldman W.P., Baty J.D., Buckles V.D., Sahrmann S., and Morris J.C. Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology 53 (1999) 956-962
16. Golob E.J., and Starr A. Effects of stimulus sequence on event-related potentials and reaction time during target detection in Alzheimer's disease. Clin. Neurophysiol. 111 (2000) 1438-1449
17. Golob E.J., Johnson J.K., and Starr A. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment. Clin. Neurophysiol. 113 (2002) 151-161
18. Golob E.J., Ovasapyan V., and Starr A. Event-related potentials accompanying motor preparation and stimulus expectancy in the young, young-old and oldest-old. Neurobiol. Aging 26 (2005) 531-542
19. Golob, E.J., Irimajiri, R., Starr, A., in press. Auditory cortical activity in amnestic mild cognitive impairment: relationship to initial subtypes and conversion to dementia. Brain.
20. Heckers S., Geula C., and Mesulam M.M. Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease. Neurobiol. Aging 13 (1992) 455-460
21. Huttunen J., Jaaskelainen I.P., Hirvonen J., Kaakkola S., Ilmoniemi R.J., and Pekkonen E. Scopolamine reduces the P35m and P60m deflections of the human somatosensory evoked magnetic fields. NeuroReport 12 (2001) 619-623
22. Irimajiri R., Golob E.J., and Starr A. Auditory brain-stem, middle- and long-latency evoked potentials in mild cognitive impairment. Clin. Neurophysiol. 116 (2005) 1918-1929
23. Jasper H.H. The ten-twenty electrode system of the international federation. Electroencephalogr. Clin. Neurophysiol. 10 (1958) 371-375
24. Kaplan E., Snodgrass H., and Weintraub S. Boston Naming Test (1983), Lea and Febiger, Philadelphia, PA
25. Kluger A., Gianutsos J.G., Golomb J., Ferris S.H., George A.E., Franssen E., and Reisberg B. Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer's disease. J. Geront., B. Psychol. Sci. Soc. Sci. 52 (1997) 28-39
26. Kordower J.H., Chu Y., Stebbins G.T., DeKosky S.T., Cochran E.J., Bennett D., and Mufson E.J. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49 (2001) 202-213
27. Lesser R.P., Koehle R., and Lueders H. Effect of stimulus intensity on short latency somatosensory evoked potentials. Electroencephalogr. Clin. Neurophysiol. 47 (1979) 377-382
28. Liegeois-Chauvel C., Musolino A., Badier J.M., Marquis P., and Chauvel P. Evoked potentials recorded from the auditory cortex in man: evaluation and topography of the middle latency components. Electroencephalogr. Clin. Neurophysiol. 92 (1994) 204-214
29. Mesulam M., Shaw P., Mash D., and Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann. Neurol. 55 (2004) 815-828
30. Metherate R. Nicotinic acetylcholine receptors in sensory cortex. Learn. Mem. 11 (2004) 50-59
31. Metherate R., Tremblay N., and Dykes R.W. The effects of acetylcholine on response properties of cat somatosensory cortical neurons. J. Neurophysiol. 59 (1988) 1231-1252
32. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., Mellits E.D., and Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 (1989) 1159-1165
33. Morris J.C., and Price A.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 17 (2001) 101-118
34. Morris J.C., Storandt M., Miller P., McKeel Jr. D.W., Price J.L., Rubin E.H., and Berg L. Mild cognitive impairment represents early-stage Alzheimer's disease. Arch. Neurol. 58 (2001) 397-405
35. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., and Kordower J.H. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol. 158 (1999) 469-490
36. Petersen R. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256 (2004) 183-194
37. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56 (1999) 303-308
38. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C.H., Thal L.J., and Group A.s.D.C.S. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352 (2005) 2379-2388
39. Pettersson A.F., Olsson E., and Wahlund L.O. Motor function in subjects with mild cognitive impairment and early Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 19 (2005) 299-304
40. Philpot M.P., Amin D., and Levy R. Visual evoked potentials in Alzheimer's disease: correlations with age and severity. Electroencephalogr. Clin. Neurophysiol. 77 (1990) 323-329
41. Reitan R.M. Validity of the trail making test as an indicator of organic brain damage. Percept. Mot. Skills 8 (1958) 271-276
42. Reite M., Teale P., Zimmerman J., Davis K., and Whalen J. Source location of a 50 msec latency auditory evoked field component. Electroencephalogr. Clin. Neurophysiol. 70 (1988) 490-498
43. Restuccia D., Della Marca G., Valeriani M., Rubino M., Paciello N., Vollono C., Capuano A., and Tonali P. Influence of cholinergic circuitries in generation of high-frequency somatosensory evoked potentials. Clin. Neurophysiol. 114 (2003) 1538-1548
44. Rogers S.L., Doody R.S., Mohs R.C., and Friedhoff L.T. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch. Intern. Med. 158 (1998) 1021-1031
45. Sloan E.P., Fenton G.W., and Standage K.P. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory. Biol. Psychiatry 31 (1992) 600-606
46. Smith G.E., Petersen R.C., Parisi J.E., Ivnik R.J., Kokmen E., Tangalos E.G., and Waring S.C. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol. Cogn. 3 (1996) 141-147
47. Spreen O., and Benton A.L. Neurosensory Center Comprehensive Examination for Aphasia (1977), Neuropsychology Laboratory, University of Victoria, Victoria, BC
48. Wechsler D. Wechsler Adult Intelligence Scale-Revised (1981), Harcourt Brace Jovanovich, New York, NY
49. Wechsler D. Wechsler Memory Scale. 3rd ed. (1997), Psychological Corporation, San Antonio
50. Winblad B., Engedal K., Soininen H., Verhey F., Waldemar G., Wimo A., Wetterholm A.L., Zhang R., Haglund A., Subbiah P., and Group P.D.N.S. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57 (2001) 489-495
51. Wright C.E., Williams D.E., Drasdo N., and Harding G.F. The influence of age on the electroretinogram and visual evoked potential. Doc. Ophthalmol. 59 (1985) 365-384
52. Wright C.E., Harding G.F., and Orwin A. The flash and pattern VEP as a diagnostic indicator of dementia. Doc. Ophthalmol. 62 (1986) 89-96
53. Yan J.H., and Dick M.B. Practice effects on motor control in healthy seniors and patients with mild cognitive impairment and early Alzheimer's disease. Aging Neuropsychol. Cogn. 13 (2006) 385-410
54. Yesavage J.A., Brink T.L., Rose T.L., Lum O., Huang V., Adey M., and Leirer V.O. Development and validation of a geriatric depression screening scale: a preliminary report. J. Psychiatr. Res. 17 (1983) 37-49